Filter programs:

46 Programs

  • ASCO 2026 Satellite

    Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway in Breast Cancer

    Explore program
    • May 2026 2.25 ABIM MOC, ABS MOC, CME 1h 58min
      • E
      • J
        Joyce O’Shaughnessy, MD
      • N
      • +2
      Dr Mayer, Dr O’Shaughnessy, Dr Turner, Dr Hurvitz, +1
  • Nursing Symposium

    Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer

    Explore program
  • Nursing Symposium

    Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer

    Explore program
  • Oncology Today

    First-Line and Maintenance Therapy for Patients with HER2-Positive Metastatic Breast Cancer

    Explore program
    • April 2026 1 ABIM MOC, ABS MOC, CME 46min
      • P
      Dr Loibl
    • April 2026 0.75 ABIM MOC, ABS MOC, CME 30min
      • P
      Dr Loibl